Optimal control strategy for cancer remission using combinatorial therapy: A mathematical model-based approach
暂无分享,去创建一个
Dibakar Ghosh | Fathalla A. Rihan | Parthasakha Das | Pritha Das | Muhammet Uzuntarla | Samhita Das | P. Das | D. Ghosh | M. Uzuntarla | Samhita Das | P. Das
[1] Parthasakha Das,et al. An investigation on Monod-Haldane immune response based tumor-effector-interleukin-2 interactions with treatments , 2019, Appl. Math. Comput..
[2] D. Kirschner,et al. Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.
[3] Shanmugam Lakshmanan,et al. Optimal control of tumour-immune model with time-delay and immuno-chemotherapy , 2019, Appl. Math. Comput..
[4] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[5] D. Kirschner,et al. A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.
[6] D. Noonan,et al. Tumor inflammatory angiogenesis and its chemoprevention. , 2005, Cancer research.
[7] John T. Workman,et al. Optimal Control Applied to Biological Models , 2007 .
[8] Dibakar Ghosh,et al. The influence of time delay in a chaotic cancer model. , 2018, Chaos.
[9] Yue Zhao,et al. Survival analysis for tumor cells in stochastic switching environment , 2019, Appl. Math. Comput..
[10] R. Weinberg,et al. The Biology of Cancer , 2006 .
[11] Jon Ernstberger,et al. OPTIMAL CONTROL APPLIED TO IMMUNOTHERAPY , 2003 .
[12] A. Misra,et al. Stochastic stability of aerosols-stimulated rainfall model , 2019, Physica A: Statistical Mechanics and its Applications.
[13] G. W. Swan. Role of optimal control theory in cancer chemotherapy. , 1990, Mathematical biosciences.
[14] Parthasakha Das,et al. Stochastic dynamics of Michaelis–Menten kinetics based tumor-immune interactions , 2020 .
[15] Parthasakha Das,et al. Effects of delayed immune-activation in the dynamics of tumor-immune interactions , 2020, Mathematical Modelling of Natural Phenomena.
[16] P. Maini,et al. Mathematical oncology: Cancer summed up , 2003, Nature.
[17] Carla M. A. Pinto,et al. The effect of aggressive chemotherapy in a model for HIV/AIDS-cancer dynamics , 2019, Commun. Nonlinear Sci. Numer. Simul..
[18] J. Schneck,et al. Adoptive T Cell Immunotherapy for Cancer , 2015, Rambam Maimonides medical journal.
[19] Kazeem O. Okosun,et al. Optimal control strategies and cost-effectiveness analysis of a malaria model , 2013, Biosyst..
[20] L. Coussens,et al. Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.
[21] F Castiglione,et al. Cancer immunotherapy, mathematical modeling and optimal control. , 2007, Journal of theoretical biology.
[22] Ranjit Kumar Upadhyay,et al. Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach , 2020 .
[23] L. S. Pontryagin,et al. Mathematical Theory of Optimal Processes , 1962 .
[24] Kusum Lata,et al. An optimal control problem for carrier dependent diseases , 2020, Biosyst..
[25] Parthasakha Das,et al. Dynamics and control of multidrug-resistant bacterial infection in hospital with multiple delays , 2020, Commun. Nonlinear Sci. Numer. Simul..
[26] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[27] A. Murugan,et al. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls. , 2007, Mathematical biosciences.
[28] J. F. Gómez‐Aguilar,et al. A chaos study of tumor and effector cells in fractional tumor-immune model for cancer treatment , 2020 .
[29] M. Perry. The Chemotherapy Source Book , 1992, Annals of Internal Medicine.
[30] John Carl Panetta,et al. Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies , 2003, SIAM J. Appl. Math..
[31] Fathalla A. Rihan,et al. Dynamics of fractional-order delay differential model for tumor-immune system , 2020 .
[32] Sylvain Mangiarotti,et al. How tumor growth can be influenced by delayed interactions between cancer cells and the microenvironment? , 2017, Biosyst..
[33] A. Radunskaya,et al. Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .
[34] Parthasakha Das,et al. Dynamics of Effector -Tumor- Interleukin-2 Interactions with Monod-Haldane Immune Response and Treatments , 2019, ICITAM.
[35] A. Misra,et al. The influence of forestry resources on rainfall: A deterministic and stochastic model , 2020 .
[36] Ranjit Kumar Upadhyay,et al. Exploring dynamical complexity in a time-delayed tumor-immune model. , 2020, Chaos.
[37] Ami Radunskaya,et al. The dynamics of an optimally controlled tumor model: A case study , 2003 .
[38] An optimal control model for cloud seeding in a deterministic and stochastic environment , 2020, Optimal Control Applications and Methods.
[39] Behzad Ghanbari,et al. A study of behaviour for immune and tumor cells in immunogenetic tumour model with non-singular fractional derivative , 2020 .
[40] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[41] P. Das,et al. Control of Nipah virus outbreak in commercial pig-farm with biosecurity and culling , 2020, Mathematical Modelling of Natural Phenomena.
[42] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[43] G. W. Swan,et al. General applications of optimal control theory in cancer chemotherapy. , 1988, IMA journal of mathematics applied in medicine and biology.
[44] Hongming Zhang,et al. Current status and future directions of cancer immunotherapy , 2018, Journal of Cancer.
[45] Parthasakha Das,et al. An investigation on Michaelis - Menten kinetics based complex dynamics of tumor - immune interaction , 2019, Chaos, Solitons & Fractals.
[46] A. Diefenbach,et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.
[47] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[48] Dibakar Ghosh,et al. A chemotherapy combined with an anti-angiogenic drug applied to a cancer model including angiogenesis , 2017 .
[49] W. Fleming,et al. Deterministic and Stochastic Optimal Control , 1975 .
[50] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[51] K Renee Fister,et al. Immunotherapy: an optimal control theory approach. , 2005, Mathematical biosciences and engineering : MBE.
[52] Santo Banerjee,et al. Characterizing chaos and multifractality in noise-assisted tumor-immune interplay , 2020, Nonlinear Dynamics.
[53] A. Hoos. Evolution of end points for cancer immunotherapy trials. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[54] R. Schreiber,et al. Natural innate and adaptive immunity to cancer. , 2011, Annual review of immunology.
[55] Dibakar Ghosh,et al. The combined effects of optimal control in cancer remission , 2015, Appl. Math. Comput..
[56] Dahlard L. Lukes,et al. Differential Equations: Classical to Controlled , 2012 .
[57] Zijian Liu,et al. Analysis of a nonlinear age-structured tumor cell population model , 2019, Nonlinear Dynamics.
[58] Kusum Lata,et al. Modeling the effect of time delay on the conservation of forestry biomass , 2013 .